Related Experiment Video
Updated: Jun 3, 2026
Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
The paradox of α-adrenergic coronary vasoconstriction revisited
1Institut für Pathophysiologie, Universitätsklinikum Essen, Hufelandstr. 55, 45122 Essen, Germany. gerd.heusch@uk-essen.de
Insights
Alpha-adrenergic vasoconstriction in coronary arteries impedes blood flow. Blocking these receptors, specifically alpha-1 and alpha-2, improves blood flow, heart function, and metabolism in patients with coronary artery disease.
Area of Science:
- Cardiovascular Physiology
- Pharmacology
- Adrenergic Receptor Signaling
Background:
- Coronary vascular alpha-adrenoceptors mediate vasoconstriction, opposing metabolic vasodilation during sympathetic activation.
- Epicardial vessels primarily involve alpha-1 adrenoceptors, while microcirculation involves alpha-2 and alpha-1 adrenoceptors.
Purpose of the Study:
- To investigate the role of alpha-adrenergic vasoconstriction in coronary blood flow regulation.
- To evaluate the effects of alpha-adrenoceptor blockade on myocardial perfusion and function.
Main Methods:
- Review of existing evidence on alpha-adrenergic receptor function in coronary circulation.
- Analysis of studies involving alpha-blockade in animal models and human patients.
Main Results:
- Alpha-adrenergic vasoconstriction does not beneficially affect transmural blood flow distribution.
- Alpha-blockade improves blood flow to all myocardial layers in dogs, under various perfusion conditions.
- In coronary artery disease patients, alpha-1 and alpha-2 adrenoceptor blockade enhances coronary blood flow, myocardial function, and metabolism.
Conclusions:
- Alpha-adrenergic coronary vasoconstriction is detrimental to blood flow and cardiac function.
- Blocking alpha-1 and alpha-2 adrenoceptors represents a potential therapeutic strategy for improving outcomes in coronary artery disease.
Abstract:
Activation of coronary vascular α-adrenoceptors results in vasoconstriction which competes with metabolic vasodilation during sympathetic activation. Epicardial conduit vessel constriction is largely mediated by α(1)-adrenoceptors; the constriction of the resistive microcirculation largely by α(2)-adrenoceptors, but also by α(1)-adrenoceptors. There is no firm evidence that α-adrenergic coronary vasoconstriction exerts a beneficial effect on transmural blood flow distribution. In fact, α-blockade in anesthetized and conscious dogs improves blood flow to all transmural layers, during normoperfusion and hypoperfusion. Also, in patients with coronary artery disease, blockade of α(1)- and α(2)-adrenoceptors improves coronary blood flow, myocardial function and metabolism.
Related Concept Videos
01:22Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
01:31Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
01:26Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
01:27Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
01:16Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers